UCLA Health

The "breathing lung" device is modified to keep organs healthier, and most importantly removing excess fluid due to neurogenic pulmonary edema.

Founded in 1982 and based in Los Angeles, the OAL tests athlete samples for various professional sports associations.

Even as she was coming to terms with the diagnosis, Ava Hernandez was dreaming of playing again.

While learning about brain tumors in medical school, Dr. Paul Lukac discovered he had one.

A gene expression test identifies the first three years after childbirth as a potential window of higher biological risk.

Director of the UCLA Space Medicine Program, Dr. Haig Aintablian, spends his days immersed in groundbreaking research and space-adjacent experiences.

The findings highlight key insights from two subsequent bladder transplants performed at UCLA Health.

The innovation hub dedicated to pioneering AI research in transformative medicine.

The Olympic Analytical Laboratory works to ensure "a true competition and not a competition of syringes."

Researchers will look to identify genetic and environmental factors that determine how fast an individual’s Parkinson’s disease progresses.

The findings may help explain sex differences in heart disease and support the development of more personalized treatments.

The study's findings could ease concerns that the expansion of telemedicine would trigger spikes in usage and costs

At UCLA, Dr. David Nathanson is designing new therapies that tackle glioblastoma’s unique tumor biology, aiming to overcome long-standing treatment challenges.

The analysis of nearly 94,000 participants in UCLA’s ATLAS Biobank highlights the value of genetic diversity in developing precision health strategies.

The test could offer a more affordable approach to early disease detection.

A fruitful partnership between Charles R. Drew University and UCLA to train doctors for underserved communities enters a new era.

By equipping T cells with two proteins derived from fungi, the researchers enabled the immune cells to import cellobiose and convert it into usable glucose inside the cell.

Study identifies cellular defense system that protects neurons from toxic tau proteins, opening door to new treatments.

A novel shape of zinc oxide helps reduce chalkiness in mineral sunscreen and makes it easier to wear, especially for people with darker skin tones.

A new UCLA study combines human and animal research to identify chlorpyrifos as a potential environmental cause of brain disease.

Sedatives and antipsychotics linked to falls, confusion, and hospitalization remain widely used in patients most vulnerable to their harms.

The new grant will fund the enrollment of 10 additional patients in the trial and support research into the science behind immune tolerance.

The annual event underscored the university’s partnership with the VA and its commitment to helping service members.

Following the team’s discovery, researchers have identified a strategy to possibly prevent treatment relapses.

The findings point to a growing public health concern for younger Americans.